RNC Pharma an analytical company has reported that from January to July 2024, the total production of finished pharmaceuticals in Russia reached 462.5 billion rubles, marking a 16% increase compared to the same period in 2023. Russian-based pharmaceutical companies shipped approximately 2.37 billion packages of medicines, reflecting a 4.6% rise since the start of the year.
The number of companies involved in shipping finished pharmaceuticals grew to 433, an increase of 21 companies. The range of active pharmaceutical ingredients (APIs) available expanded to 1,433, up by 56, while the number of trade names rose to 2,779, an increase of 123.
Among the largest companies, “Sotex” showed the highest growth in the prescription drug segment, with a 89.6% increase in packages shipped. Production at Sotex’s facilities surged by 3.6 times. Additionally, 47 manufacturers of prescription drugs doubled their output compared to January–July 2023, although collectively, they represent just 2.5% of the total volume.
On the other hand, seven top producers saw a decline in their production volumes. This group includes major suppliers such as “Pharmstandard” (-2%), Ozon (-17%), and STADA (-22%). In the top 20, “Obnovenie” recorded the highest growth in volume, with a 58.8% increase. Significant growth was also seen from “Uralbiofarm” (+33%) and “Valenta” (+26.6%).
